Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Assets: 2021-2025

Historic Assets for Roivant Sciences (ROIV) over the last 5 years, with Mar 2025 value amounting to $5.4 billion.

  • Roivant Sciences' Assets fell 18.42% to $5.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.1 billion, marking a year-over-year decrease of 18.42%. This contributed to the annual value of $5.4 billion for FY2025, which is 24.72% down from last year.
  • Per Roivant Sciences' latest filing, its Assets stood at $5.4 billion for FY2025, which was down 6.14% from $5.8 billion recorded in FY2024.
  • Roivant Sciences' 5-year Assets high stood at $7.3 billion for FY2023, and its period low was $2.2 billion during FY2022.
  • In the last 3 years, Roivant Sciences' Assets had a median value of $5.8 billion in 2024 and averaged $5.6 billion.
  • In the last 5 years, Roivant Sciences' Assets spiked by 231.95% in 2023 and then dropped by 24.72% in 2025.
  • Over the past 5 years, Roivant Sciences' Assets (Yearly) stood at $2.6 billion in 2021, then reached $2.8 billion in 2021, then dropped by 0.18% to $2.6 billion in 2022, then dropped by 21.31% to $2.2 billion in 2022, then declined by 7.56% to $2.4 billion in 2023, then skyrocketed by 231.95% to $7.3 billion in 2023, then skyrocketed by 202.25% to $7.2 billion in 2024, then dropped by 20.79% to $5.8 billion in 2024, then decreased by 24.72% to $5.4 billion in 2025.